Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
about
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesBig Data Offers Novel Insights for Oncolytic Virus ImmunotherapyThe Role of Intestinal Microbiota in Acute Graft-versus-Host DiseaseThe Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host DiseaseDanger Signals and Graft-versus-host Disease: Current Understanding and Future PerspectivesTLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseTherapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHDVarious forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.Intestinal microbiota-related effects on graft-versus-host disease.Microbiota—implications for immunity and transplantation.Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation.Role of the intestinal mucosa in acute gastrointestinal GVHD.The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation.Regulation of tissue infiltration by neutrophils: role of integrin α3β1 and other factors.Busulfan and cyclosphamide induce liver inflammation through NLRP3 activation in mice after hematopoietic stem cell transplantation.Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyPreclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.Recent advances on cellular therapies and immune modulators for graft-versus-host disease.Insights into the pathogenesis of GvHD: what mice can teach us about man.Biological Activities of Reactive Oxygen and Nitrogen Species: Oxidative Stress versus Signal Transduction.Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.Immune deficiency vs. immune excess in inflammatory bowel diseases-STAT3 as a rheo-STAT of intestinal homeostasis.Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.Hydrogen, a potential safeguard for graft-versus-host disease and graft ischemia-reperfusion injury?RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injuryNLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis.The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections.Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress.Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.G-CSF-Induced Suppressor IL-10+ Neutrophils Promote Regulatory T Cells That Inhibit Graft-Versus-Host Disease in a Long-Lasting and Specific Way.Plasma vascular non-inflammatory molecule 3 is associated with gastrointestinal acute graft-versus-host disease in mice.The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.
P2860
Q26751959-455770FB-2B71-48A0-85F7-4DC5D2677C6FQ26767209-04F28574-08AE-4CFF-8AFF-F303978C9F0FQ27008309-6CD389E3-92A8-4D4A-B236-395164BB32CDQ28068647-CE8BF8EE-A70C-4AF2-AC5D-4AA9F1B809A2Q28075204-FA3028ED-83E4-4208-BA00-FB22F8331B78Q33835099-5A6E98E9-8A36-45FB-A697-BC5FD5365CE0Q34974093-D954285F-68BA-455D-8EC7-2F2B3D3207E9Q35022269-FFFCBFFD-1A4E-4ABD-BC98-0A1D77230066Q35179622-7A041E05-62CA-4D03-9A68-E039E476FDADQ35587907-5A1A863F-7752-46DD-8694-99DA9C7FD6BAQ35627459-32CE6B7D-0C9A-4156-97EE-D8206B7BDC96Q35737437-9CDB6C71-3B56-415F-81F0-ED281339DB80Q36056986-1E97CD95-D6E3-4E68-903D-68E8A299D5EFQ36130498-57FC3482-7777-40C7-8D06-94073BB830F9Q36212428-5A03A470-1D2B-4353-BC6F-608866333CD9Q36264109-677DD1E7-84A4-4E20-832A-1B5386855783Q36342909-AFB52FFB-705D-4337-B5E4-2EFAC9A065AFQ36346253-F3D67D31-2144-4EAA-92AA-07992BBCBB1DQ36862931-C9B85C6E-4F54-4A0B-B194-6421D3165878Q37035815-0D422920-7E2C-4163-AD94-65B99EC6E8C7Q37191056-FDD496E7-66D2-4DE3-B580-0803A6D5A6B6Q38246755-4154B39D-0308-4E46-A37B-C2BF587D2C7BQ38297240-A4A046C1-B8B1-4A17-8558-333A461A1136Q38425735-8CF64287-A77A-4A9F-968E-EE7B6CB3295AQ38460376-04541C8E-A689-4C63-A54C-6E6A724625BAQ38558749-E58B3D34-DE12-4DA1-9ED0-E0027BB06835Q38598016-45DC6D35-082B-4BA1-8E78-6F7DC7CFB519Q38685479-869703D1-5E8C-4818-85E9-586D9DCD0FDEQ38743931-5E8AD8F6-434B-4AB5-B0B4-7A28CA9CE568Q38819068-A76C3B00-C578-457C-A5E0-7CCDBBBC0CDBQ38829671-3ED48ED5-937A-4F47-B3B2-7990F614595BQ38853974-015820C6-03D4-43AD-8503-B5D1D36A7D60Q39000116-240E2817-206C-45BB-A09B-6B5BDE4893BDQ39429504-730BF95A-C3DF-48EA-8691-5BC4A7991A43Q40174699-17EFB36C-27C5-4C2D-B3BC-51364692FCC3Q41995284-6D7BE5A2-4D69-4F89-9CD4-C6C8627DB607Q46481410-D4FED7A8-EB69-4272-8941-6A34566B66EBQ47222414-D830C0B1-0B7D-4BBD-8A57-7062C5C02D7AQ49384876-48CED3BB-7FC2-4990-ADF6-3363ED2A8DAFQ49679320-03307660-7255-4FE4-B418-528DA1D0C0FD
P2860
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@ast
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@en
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@nl
type
label
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@ast
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@en
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@nl
prefLabel
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@ast
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@en
Neutrophil granulocytes recrui ...... ost disease via tissue damage.
@nl
P2093
P2860
P50
P356
P1433
P1476
Neutrophil granulocytes recrui ...... host disease via tissue damage
@en
P2093
Anne Schönle
Annette Schmitt-Graeff
Antigoni Triantafyllopoulou
Dietmar Pfeifer
Franziska Leonhardt
Fridrik J Karlsson
Friederike D von Loewenich
Georg Häcker
Gerhard C Hildebrandt
Hans Häcker
P2860
P2888
P304
P356
10.1038/NM.3517
P407
P577
2014-05-18T00:00:00Z